Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Articaine vs Mepivacaine for IUD Insertion Pain
NCT05252117Phase 4Unknown
- Sponsor
- Universidade do Vale do Sapucaí
- Start
- Feb 2021
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of articaine in procedural pain (2 arms), sponsored by Universidade do Vale do Sapucaí. Primary endpoint: Pain assessment at 15 months. Status: unknown.
02
Drugs
articaine
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT05252117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05252117.